NCT04405193View on ClinicalTrials.gov

The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

July 30, 2020

Study Completion Date

December 30, 2020

Conditions
Methamphetamine Dependence in Remission
Interventions
DRUG

N-acetyl cysteine

Eligible patients will be randomised to receive N-acetylcysteine or placebo

DRUG

Placebo

Matching Placebo

Trial Locations (1)

16110

Rehabilitation Center, National Narcotics Agency, Bogor

All Listed Sponsors
lead

Melva Louisa

OTHER

NCT04405193 - The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms | Biotech Hunter | Biotech Hunter